Diabetes mellitus im Alter

Abstract

Diabetes in old age is one of the most common chronical diseases by a prevalence of up to 25 % of the 70-year and older patients. Elderly with diabetes often suffer from functional or cognitive deficits that must be realized for therapeutic issues. These would include special geriatric syndromes like frailty, falls, immobility or higher vulnerability for drug interactions. Therefore the German Diabetes Association recommends to adjust therapeutic goals not only to patients’ goals but also to their individual functional status. Simple therapy regimens should be preferred to avoid polypharmacia and to preserve the patients’ independence as long as possible.

Diabetes im Alter ist eine der häufigsten chronischen Erkrankungen mit einer Prävalenz von bis zu 25 % bei den über 70-Jährigen. Ältere Menschen mit Diabetes haben häufig funktionelle und/oder kognitive Beeinträchtigungen – diese müssen bei der Therapieplanung berücksichtigt werden. Dieser Beitrag stellt die Empfehlungen der Deutschen Diabetes Gesellschaft hinsichtlich der Behandlungsziele für ältere Menschen mit Diabetes vor.

Schlüsselwörter

Diabetes im Alter - funktionelle Defizite - geriatrische Syndrome - Therapieziele

Key words

diabetes of old age - functional deficit - geriatric syndroms - therapeutic goals

• Literatur

• 1 Holman RR, Paul SK, Bethel MA. et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359: 1577-1589
• 2 Gerstein HC, Miller ME, Byington RP. et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545-2559
• 3 Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group. Modern-day clinical course of type 1 diabetes mellitus after 30 years’ duration. Arch Intern Med 2009; 169: 1307-1316
• 4 Gaede P, Lund-Andersen H, Parvin HH. et al. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008; 358: 580-591
• 5 Zinman B, Wanner C, Lachin JM. et al. Empagliflozin, cardiovascular outcomes and mortality in type 2 diabetes. N Engl J Med 2015; 373: 2117-2128
• 6 Tamayo T, Brinks R, Hoyer A. et al. The prevalence and incidence of diabetes in Germany. Dtsch Arztebl Int 2016; 113: 177-1782
• 7 Landi F, Liperoti R, Russo A. et al. Disability, more than multimorbidity, was predictive of mortality among older persons aged 80 years and older. J Clin Epidemiol 2010; 63: 752-759
• 8 Tancredi M, Rosengren A, Svensson AM. et al. Excess mortality among persons with type 2 diabetes. N Engl J Med 2015; 373: 1720-1732
• 9 Zeyfang A, Wernecke J, Bahrmann A. Diabetes mellitus im Alter. Diabetologie 2018; 13 (Suppl. 02) S185-S191
• 10 Verny C, Ducet J, Bauduceau B. et al. Prevalence of cognitive decline and associated factors in elderly type 2 diabetic patients at inclusion in the GERODIAB cohort. Eur Geriatr Med 2015; 6: 36-40
• 11 Vetrano DL, Landi F, Volpato S. et al. Association of sarcopenia with short- and long-term mortality in older adults admitted to acute care wards: results from the CRIME study. J Gerontol A Bio Sci Med Sci 2014; 69: 1154-1161
• 12 Fried LP, Tangen CM, Walston J. et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56: 146-156
• 13 Rockwood K, Mitniski AB, MacKnight C. Some mathematical models of frailty and their clinical implications. Rev Clin Gerontol 2002; 12: 109-117
• 14 Rockwood K, Song X, MacKnight C. et al. A global clinical measure of fitness and frailty in elderly people. CMAJ 2005; 173: 489-495
• 15 Bergman H, Ferrucci L, Guralnik J. et al. Frailty: an emerging research and clinical paradigm – issues and controversies. J Gerontol A Biol Sci Med Sci 2007; 62: 731-737
• 16 Leenders M, Verdijk LB, van der Hoeven L. et al. Patients with type 2 diabetes show a greater decline in muscle mass, muscle strength, and functional capacity with aging. J Am Med Dir Assoc 2013; 14: 585-592
• 17 Bendayan M, Bibas L, Levi M. et al. Therapeutic interventions for frail elderly patients: part II. Ongoing and unpublished randomized trials. Prog Cardiovasc Dis 2014; 57: 144-151
• 18 Rooks D, Praestgaard J, Hariry S. et al. Treatment of sarcopenia with bimagrumab: Results from a phase II, randomized, controlled, proof-of-concept study. J Am Geriatr Soc 2017; 65: 1988-1995
• 19 Bahrmann A, Bahrmann P, Baumann J. et al. S2k-Leitlinie Diagnostik, Therapie und Verlaufskontrolle des Diabetes im Alter. Diabetologie 2018; 13: 423-489
• 20 Kimbor LB, Mangione CM, Steers WN. et al. Depression and all‐cause mortality in persons with diabetes mellitus: are older adults at higher risk? Results from the translating research into action for diabetes study. J Am Geriatr Soc 2014; 62: 2017-2022
• 21 Jackson SL, Scholes D, Boyko EJ. et al. Urinary incontinence and diabetes in postmeopausal women. Diabetes Care 2005; 28: 1730-1738
• 22 Haefeli WE. Informationen zur Arzneimittel-Anwendung & -Sicherheit: Dosierung bei Niereninsuffizienz. 2019 Im Internet: http://www.dosing.de/nierebck.php ; Stand: 07.11.2019
• 23 Zeyfang A, Berndt S, Aurnhammer G. et al. A short easy test can detect ability for autonomous insulin injection by the elderly with diabetes mellitus. J Am Med Dir Assoc 2012; 13: 81.e15–18
• 24 Yaffe K, Falvey CM, Hamilton N. et al. Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Intern Med 2013; 173: 1300-1306
• 25 Escobar C, Blanes I, Ruiz A. et al. Prevalence and clinical profile and management of peripheral arterial disease in elderly patients with diabetes. Eur J Intern Med 2011; 22: 275-281
• 26 Deutsche Diabetes Gesellschaft. Diabetes-Pflegefachkraft DDG (Klinik). Im Internet: http://www.deutsche-diabetes-gesellschaft.de/weiterbildung/diabetes-pflegefachkraft-ddg-klinik.html ; Stand: 07.11.2019